← Evidence map

ReviewDrugs2000

Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.

D Clemett et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2000

this paperpooled itcites it

Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease. | OpenQuestion